NPDT Evaluation in Children With CFTR and (PSC)

Completed

Conditions studied: Primary Sclerosing Cholangitis, Inflammatory Bowel Disease

In brief

The investigators hypothesize that PSC in children is associated with mutations and functional changes of the cystic fibrosis (CF) gene.

Key facts

Study ID

NCT00179439

Run by

Beth Israel Deaconess Medical Center

People needed

50

Starts

2004-01-01

Expected to finish

2006-01-01

Last updated by the study team

2017-12-13

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 12 years of age and older
• Must have diagnosis of primary sclerosing cholangitis and/or inflammatory bowel disease
• Absence of other liver disease, such as viral hepatitis, drug-induced liver disease, and metabolic/hereditary liver disease
• No exclusion based on sex, race, and ethnic background

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.